Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | BRD4 | O60885 | 1/20 | 0.44 |
| ▸ | KDM1A | O60341 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3727149 | 0.80 | ALDH1A1 (0.58) | RAB9ASMN1; SMN2NPC1ALDH1A1HPGD | |
| SCHEMBL3731106 | 0.80 | ALDH1A1 (0.55) | RAB9ASMN1; SMN2NPC1ALDH1A1HPGD | |
| SCHEMBL3727157 | 0.71 | MEN1 (0.72) | RAB9ASMN1; SMN2NPC1ALDH1A1HPGD | |
| SCHEMBL13347438 | 0.71 | KDM1A (0.54) | RAB9ASMN1; SMN2NPC1ALDH1A1HPGD | |
| SCHEMBL358044 | 0.71 | KDM1A (0.57) | SMN1; SMN2ALDH1A1HPGDMAPTLMNA | |
| SCHEMBL3728504 | 0.70 | ALDH1A1 (0.56) | RAB9ASMN1; SMN2NPC1ALDH1A1HPGD | |
| SCHEMBL3738421 | 0.70 | ALDH1A1 (0.58) | RAB9ASMN1; SMN2NPC1ALDH1A1HPGD | |
| SCHEMBL3727761 | 0.70 | LMNA (0.65) | RAB9ASMN1; SMN2NPC1ALDH1A1HPGD | |
| SCHEMBL12218606 | 0.70 | RAB9A (1.00) | RAB9ASMN1; SMN2NPC1ALDH1A1HPGD | |
| SCHEMBL3729052 | 0.69 | HTT (0.74) | RAB9ASMN1; SMN2NPC1ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100120669-A1 | THIADIAZOLE DERIVATIVES, INHIBITORS OF STEAROYL-COA DESATURASE | BOUILLOT ANNE MARIE JEANNE | 2010-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100120669-A1 | THIADIAZOLE DERIVATIVES, INHIBITORS OF STEAROYL-COA DESATURASE | SCD, SCD5, FADS2 | RAB9A 3330/4885SMN1; SMN2 2732/4885NPC1 416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.